About Abyrx
Abyrx is a company based in Irvington (United States) founded in 2013.. Abyrx has raised $10 million across 1 funding round from investors including Canaan, BB Biotech Ventures and MedEdge Solutions. Abyrx has completed 1 acquisition, including ORTHOCON. Abyrx offers products and services including MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe. Abyrx operates in a competitive market with competitors including Biom'Up, Prytime Medical Devices, Endomedix, United Health Products and LifeBond, among others.
- Headquarter Irvington, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abyrx, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abyrx
Abyrx offers a comprehensive portfolio of products and services, including MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Settable, resorbable hemostatic bone putty for surgical bleeding control.
Water-soluble putty for stopping bone bleeding in medical procedures.
Syringe applicator for precise hemostatic bone putty delivery.
Unlock access to complete
Funding Insights of Abyrx
Abyrx has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $10.0M
-
First Round
First Round
(06 Dec 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Series A - Abyrx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abyrx
Abyrx has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, BB Biotech Ventures and MedEdge Solutions. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
MedEdge Solutions is focused on pharmacy data and management solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abyrx
Abyrx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ORTHOCON. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Resorbable hemostatic bone putty is developed to stop surgical bleeding.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Abyrx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abyrx Comparisons
Competitors of Abyrx
Abyrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biom'Up, Prytime Medical Devices, Endomedix, United Health Products and LifeBond, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hemostatic products for surgical applications are developed using collagen-based materials.
|
|
| domain | founded_year | HQ Location |
Developer of minimally invasive large vessel occludes for hemorrhage control in trauma patients
|
|
| domain | founded_year | HQ Location |
Hydrogel solutions for surgery and wound care are developed.
|
|
| domain | founded_year | HQ Location |
Medical device for hemostasis during surgical procedures is provided.
|
|
| domain | founded_year | HQ Location |
Absorbable surgical sealants and hemostats are developed for leakage prevention.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abyrx
Frequently Asked Questions about Abyrx
When was Abyrx founded?
Abyrx was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Where is Abyrx located?
Abyrx is headquartered in Irvington, United States. It is registered at Irvington, New Jersey, United States.
Is Abyrx a funded company?
Abyrx is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Dec 06, 2016.
What does Abyrx do?
Abyrx was founded in 2013 and is headquartered in Irvington, United States. Hemostatic bone putty is developed by the company for use in surgical procedures to control bone bleeding. A portfolio of three FDA-cleared putties, which are resorbable and synthetic without tissue components, is maintained. Over 40 issued and pending patents are held. The HEMASORB Resorbable Hemostatic Bone Putty portfolio was acquired to expand offerings in the medical device sector.
Who are the top competitors of Abyrx?
Abyrx's top competitors include Prytime Medical Devices, Arch Therapeutics and Biom'Up.
What products or services does Abyrx offer?
Abyrx offers MONTAGE, Hemostatic Bone Putty, and Hemostatic Bone Putty in Syringe.
How many acquisitions has Abyrx made?
Abyrx has made 1 acquisition, including ORTHOCON.
Who are Abyrx's investors?
Abyrx has 3 investors. Key investors include Canaan, BB Biotech Ventures, and MedEdge Solutions.